Huons Global Co., Ltd. (KOSDAQ:084110)

South Korea flag South Korea · Delayed Price · Currency is KRW
57,500
+3,300 (6.09%)
At close: Dec 5, 2025
69.62%
Market Cap 701.67B
Revenue (ttm) 825.44B
Net Income (ttm) 24.39B
Shares Out 12.20M
EPS (ttm) 1,999.54
PE Ratio 28.76
Forward PE n/a
Dividend 680.00 (1.25%)
Ex-Dividend Date Nov 24, 2025
Volume 68,645
Average Volume 71,221
Open 55,000
Previous Close 54,200
Day's Range 53,600 - 57,600
52-Week Range 31,500 - 65,900
Beta 1.05
RSI 57.58
Earnings Date Nov 10, 2025

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami... [Read more]

Sector Healthcare
Founded 1965
Employees 118
Stock Exchange KOSDAQ
Ticker Symbol 084110
Full Company Profile

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.

Financial Statements

News

There is no news available yet.